Aptamer-based Emerging Tools for Viral Biomarker Detection: A Focus on SARS-CoV-2

Author:

Yüce Meral1,Kulabhusan Prabir Kumar2,Pishva Parsa3,Çapkın Eda3,Tambe Prajakta4

Affiliation:

1. Sabanci University, SUNUM Nanotechnology Research, and Application Centre, Istanbul, 34956, Turkey

2. Institute for Global Food Security, School of Biological Sciences, Queen’s University Belfast, Belfast, UK

3. Sabanci University, Faculty of Engineering and Natural Sciences, Istanbul, 34956, Turkey

4. Wellcome-- Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, UK

Abstract

Abstract: Viral infections can cause fatal illnesses to humans as well as animals. Early detection of viruses is therefore crucial to provide effective treatment to patients. Recently, the Covid-19 pandemic has undoubtedly given an alarming call to develop rapid and sensitive detection platforms. The viral diagnostic tools need to be fast, affordable, and easy to operate with high sensitivity and specificity equivalent or superior to the currently used diagnostic methods. The present detection methods include direct detection of viral antigens or measuring the response of antibodies to viral infections. However, the sensitivity and quantification of the virus are still a significant challenge. Detection tools employing synthetic binding molecules like aptamers may provide several advantages over the conventional methods that use antibodies in the assay format. Aptamers are highly stable and tailorable molecules and are therefore ideal for detection and chemical sensing applications. This review article discusses various advances made in aptamer-based viral detection platforms, including electrochemical, optical, and colorimetric methods to detect viruses, specifically SARS-Cov-2. Considering the several advantages, aptamers could be game-changing in designing high-throughput biosensors for viruses and other biomedical applications in the future.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Reference154 articles.

1. Reperant L.A.; Osterhaus A.D.M.E.; AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next? Vaccine 2017,35(35 Pt A),4470-4474

2. Wang C.; Wang D.; Abbas J.; Duan K.; Mubeen R.; Global financial crisis, smart lockdown strategies, and the COVID-19 spillover impacts: A global perspective implications from southeast asia. Front Psychiatry 2021,12,643783

3. SARS Basics Fact Sheet. Centers for Disease Control and Prevention (C)OD)Available from: (Accessed on: November 11, 2021).2017

4. Nazimek K.; Bociaga-Jasik M.; Bryniarski K.; Gałas A.; Garlicki A.; Gawda A.; Gawlik G.; Gil K.; Kosz-Vnenchak M.; Mrozek-Budzyn D.; Olszanecki R.; Piatek A.; Zawilińska B.; Marcinkiewicz J.; Ebola virus disease. Folia Med Cracov 2014,54(3),5-16

5. Kazmi S.S.; Ali W.; Bibi N.; Nouroz F.; A review on Zika virus outbreak, epidemiology, transmission and infection dynamics. J Biol Res (Thessalon) 2020,27,5

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3